Andreas J. Vogg
Aachen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Nectin-4-Targeted Radiotheranostics for Personalized Cancer Therapy: A Systematic Review.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 16, 2025
Androgen receptor blockade and its effect on PSMA-localization in prostate cancer: Implications for radioligand therapy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 05, 2025
68Ga-radiolabeled fluorescent dye for potential non-invasive multimodal imaging of subarachnoid hemorrhage.
Journal: EJNMMI radiopharmacy and chemistry
Published: March 26, 2025
Correction to: HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 20, 2024
Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer.
Journal: EJNMMI research
Published: February 10, 2023
Improved protocol for the radiosynthesis of [18 F]FTC-146: A potent and selective sigma-1 receptor radioligand.
Journal: Journal of labelled compounds & radiopharmaceuticals
Published: June 10, 2022
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer.
Journal: EJNMMI research
Published: May 02, 2022
[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 30, 2021
Labelling via [Al18F]2+ Using Precomplexed Al-NODA Moieties.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 28, 2021
Last Updated: 09/26/2026